Literature DB >> 25475954

Increasing the power of the Mann-Whitney test in randomized experiments through flexible covariate adjustment.

Karel Vermeulen1, Olivier Thas, Stijn Vansteelandt.   

Abstract

The Mann-Whitney U test is frequently used to evaluate treatment effects in randomized experiments with skewed outcome distributions or small sample sizes. It may lack power, however, because it ignores the auxiliary baseline covariate information that is routinely collected. Wald and score tests in so-called probabilistic index models generalize the Mann-Whitney U test to enable adjustment for covariates, but these may lack robustness by demanding correct model specification and do not lend themselves to small sample inference. Using semiparametric efficiency theory, we here propose an alternative extension of the Mann-Whitney U test, which increases its power by exploiting covariate information in an objective way and which lends itself to permutation inference. Simulation studies and an application to an HIV clinical trial show that the proposed permutation test attains the nominal Type I error rate and can be drastically more powerful than the classical Mann-Whitney U test.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clinical trials; covariate adjustment; permutation test; power; probabilistic index models

Mesh:

Substances:

Year:  2014        PMID: 25475954     DOI: 10.1002/sim.6386

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  A Comprehensive Lifestyle Intervention to Prevent Type 2 Diabetes and Cardiovascular Diseases: the German CHIP Trial.

Authors:  Katharina Wennehorst; Klas Mildenstein; Brunhild Saliger; Corinna Tigges; Hans Diehl; Thomas Keil; Heike Englert
Journal:  Prev Sci       Date:  2016-04

2.  Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation.

Authors:  Wanda Phipatanakul; David T Mauger; Theresa W Guilbert; Leonard B Bacharier; Sandy Durrani; Daniel J Jackson; Fernando D Martinez; Anne M Fitzpatrick; Amparito Cunningham; Susan Kunselman; Lisa M Wheatley; Cindy Bauer; Carla M Davis; Bob Geng; Kirsten M Kloepfer; Craig Lapin; Andrew H Liu; Jacqueline A Pongracic; Stephen J Teach; James Chmiel; Jonathan M Gaffin; Matthew Greenhawt; Meera R Gupta; Peggy S Lai; Robert F Lemanske; Wayne J Morgan; William J Sheehan; Jeffrey Stokes; Peter S Thorne; Hans C Oettgen; Elliot Israel
Journal:  Contemp Clin Trials       Date:  2020-11-24       Impact factor: 2.261

3.  Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes.

Authors:  David Benkeser; Iván Díaz; Alex Luedtke; Jodi Segal; Daniel Scharfstein; Michael Rosenblum
Journal:  medRxiv       Date:  2020-06-11

4.  Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes.

Authors:  David Benkeser; Iván Díaz; Alex Luedtke; Jodi Segal; Daniel Scharfstein; Michael Rosenblum
Journal:  Biometrics       Date:  2020-10-11       Impact factor: 1.701

5.  SPK1/S1P axis confers gastrointestinal stromal tumors (GISTs) resistance of imatinib.

Authors:  Yan Chen; Rui Zhang; Dandan Mi; Qiuju Wang; Tingwenli Huang; Xinwei Dong; Hongwei Zhang; Hongtao Xiao; Sanjun Shi
Journal:  Gastric Cancer       Date:  2022-08-24       Impact factor: 7.701

6.  Rapid Electronic Capturing of Patient-Reported Outcome Measures in Older Adults With End-Stage Renal Disease: A Feasibility Study.

Authors:  Jennifer Gabbard; Christopher J McLouth; Gretchen Brenes; Sophie Claudel; Samantha Ongchuan; John Burkart; Nicholas Pajewski; Kathryn E Callahan; Jeff D Williamson; Mariana Murea
Journal:  Am J Hosp Palliat Care       Date:  2020-09-16       Impact factor: 2.090

7.  Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA).

Authors:  Stavros Stivaros; Shruti Garg; Jonathan Green; Maria Tziraki; Ying Cai; Owen Thomas; Joseph Mellor; Andrew A Morris; Carly Jim; Karolina Szumanska-Ryt; Laura M Parkes; Hamied A Haroon; Daniela Montaldi; Nicholas Webb; John Keane; Francisco X Castellanos; Alcino J Silva; Sue Huson; Stephen Williams; D Gareth Evans; Richard Emsley
Journal:  Mol Autism       Date:  2018-02-22       Impact factor: 7.509

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.